285 related articles for article (PubMed ID: 15312851)
1. Role of the endothelium in modulating neointimal formation: vasculoprotective approaches to attenuate restenosis after percutaneous coronary interventions.
Kipshidze N; Dangas G; Tsapenko M; Moses J; Leon MB; Kutryk M; Serruys P
J Am Coll Cardiol; 2004 Aug; 44(4):733-9. PubMed ID: 15312851
[TBL] [Abstract][Full Text] [Related]
2. Coronary artery restenosis: a paradigm of current treatment approaches.
Kiernan TJ; Kiernan GD; Yan BD
Minerva Cardioangiol; 2009 Feb; 57(1):77-94. PubMed ID: 19202520
[TBL] [Abstract][Full Text] [Related]
3. Restenosis related to percutaneous coronary intervention has been solved?
Kivelä A; Hartikainen J
Ann Med; 2006; 38(3):173-87. PubMed ID: 16720432
[TBL] [Abstract][Full Text] [Related]
4. [Progress in researches of in-vivo re-endothelialization at the site of implanting cardiovascular devices].
Chen J; Li Q; Chen J; Huang N
Sheng Wu Yi Xue Gong Cheng Xue Za Zhi; 2009 Dec; 26(6):1380-3. PubMed ID: 20095508
[TBL] [Abstract][Full Text] [Related]
5. The vessel wall reaction in restenosis.
Schwartz RS
Semin Interv Cardiol; 1997 Jun; 2(2):83-8. PubMed ID: 9546996
[TBL] [Abstract][Full Text] [Related]
6. Applying drug-eluting stents in clinical practice.
King SB
Am J Cardiol; 2007 Sep; 100(5A):25K-31K. PubMed ID: 17719350
[TBL] [Abstract][Full Text] [Related]
7. Sirolimus- and taxol-eluting stents differ towards intimal hyperplasia and re-endothelialization.
Liuzzo JP; Ambrose JA; Coppola JT
J Invasive Cardiol; 2005 Sep; 17(9):497-502. PubMed ID: 16145242
[TBL] [Abstract][Full Text] [Related]
8. Factors influencing restenosis after coronary angioplasty.
Popma JJ; Topol EJ
Am J Med; 1990 Jan; 88(1N):16N-24N. PubMed ID: 2195881
[TBL] [Abstract][Full Text] [Related]
9. Inflammation and restenosis after percutaneous coronary interventions.
Toutouzas K; Colombo A; Stefanadis C
Eur Heart J; 2004 Oct; 25(19):1679-87. PubMed ID: 15451145
[TBL] [Abstract][Full Text] [Related]
10. Coronary artery stents: Part I. Evolution of percutaneous coronary intervention.
Newsome LT; Kutcher MA; Royster RL
Anesth Analg; 2008 Aug; 107(2):552-69. PubMed ID: 18633035
[TBL] [Abstract][Full Text] [Related]
11. Vitamin A: a drug for prevention of restenosis/reocclusion after percutaneous coronary intervention?
Gidlöf AC; Ocaya P; Krivospitskaya O; Sirsjö A
Clin Sci (Lond); 2008 Jan; 114(1):19-25. PubMed ID: 18047466
[TBL] [Abstract][Full Text] [Related]
12. Promoting vascular regeneration as an alternative to conventional angioplasty-based intervention.
Noordeloos AM; Soullié T; Duckers HJ; Serruys PW
Endothelium; 2006; 13(6):431-9. PubMed ID: 17169775
[TBL] [Abstract][Full Text] [Related]
13. Drug-eluting stents: preventing restenosis.
Slavin L; Chhabra A; Tobis JM
Cardiol Rev; 2007; 15(1):1-12. PubMed ID: 17172878
[TBL] [Abstract][Full Text] [Related]
14. Is inflammation a contributor for coronary stent restenosis?
Li JJ; Nie SP; Zhang CY; Gao Z; Zheng X; Guo YL
Med Hypotheses; 2007; 68(5):945-51. PubMed ID: 17045418
[TBL] [Abstract][Full Text] [Related]
15. Outcome of percutaneous hybrid coronary revascularization: bare metal stents jeopardize the benefit of sirolimus-eluting stents in the real world.
Fineschi M; Gori T; Pierli C; Casini S; Sinicropi G; Buti A; Del Pasqua A; Bravi A
Can J Cardiol; 2005 Dec; 21(14):1281-5. PubMed ID: 16341297
[TBL] [Abstract][Full Text] [Related]
16. The pathophysiology and burden of restenosis.
Weintraub WS
Am J Cardiol; 2007 Sep; 100(5A):3K-9K. PubMed ID: 17719351
[TBL] [Abstract][Full Text] [Related]
17. Current drug-eluting stents in complex patients and lesions.
Elezi S; Dibra A; Schömig A; Kastrati A
Minerva Cardioangiol; 2006 Feb; 54(1):5-22. PubMed ID: 16467738
[TBL] [Abstract][Full Text] [Related]
18. Preventing restenosis in early drug-eluting stent era: recent developments and future perspectives.
Birkenhauer P; Yang Z; Gander B
J Pharm Pharmacol; 2004 Nov; 56(11):1339-56. PubMed ID: 15525440
[TBL] [Abstract][Full Text] [Related]
19. A novel drug-eluting stent coated with an integrin-binding cyclic Arg-Gly-Asp peptide inhibits neointimal hyperplasia by recruiting endothelial progenitor cells.
Blindt R; Vogt F; Astafieva I; Fach C; Hristov M; Krott N; Seitz B; Kapurniotu A; Kwok C; Dewor M; Bosserhoff AK; Bernhagen J; Hanrath P; Hoffmann R; Weber C
J Am Coll Cardiol; 2006 May; 47(9):1786-95. PubMed ID: 16682302
[TBL] [Abstract][Full Text] [Related]
20. Endothelial cell migration onto metal stent surfaces under static and flow conditions.
Sprague EA; Luo J; Palmaz JC
J Long Term Eff Med Implants; 2000; 10(1-2):97-110. PubMed ID: 10947633
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
